Age-associated testosterone decline in men: Clinical issues for psychiatry

American Journal of Psychiatry

Volumn 155, Issue 10, 1998, Pages 1310-1318

  Sternbach, Harvey ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; ESTRADIOL; FOLLITROPIN; INSULIN; LUTEINIZING HORMONE; PRASTERONE; SOMATOMEDIN C; TESTOSTERONE; THYROTROPIN;

AGING; ANDROPAUSE; ARTICLE; COGNITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INDIVIDUALIZATION; MALE; MENOPAUSE; NORMAL HUMAN; PRIORITY JOURNAL; SEXUAL FUNCTION; SYMPTOMATOLOGY; TESTOSTERONE BLOOD LEVEL;

EID: 0031703817     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.155.10.1310     Document Type: Article

References (81)

1. Lamberts SW, van den Beld AW, van der Lely AJ: The endocrinology of aging. Science 1997; 278:419-424
2. Tenover JL: Testosterone and the aging male. J Androl 1997; 18:103-106
3. Schow DA, Redmon B, Pryor JL: Male menopause: how to define it, how to treat it. Postgrad Med 1997; 101:62-79
4. Vermeulen A: The male climacterium. Ann Med 1993; 25: 531-534
5. Morley JE, Kaiser FE, Sih R, Hajjar R, Perry HM III: Testosterone and frailty. Clin Geriatr Med 1997; 13:685-695
6. Swerdloff RS, Wang C: Androgen deficiency and aging in men. West J Med 1993; 159:579-585
7. Hamilton D: The Monkey Gland Affair. London, Chatto & Windus, 1986
8. Brown-Sequard CE: The effects produced on man by subcutaneous injections of a liquid obtained from the testicles of animals. Lancet 1889; 2:105-107
9. Bharke MS, Yesalis CE III, Wright JE: Psychological and behavioral effects of endogenous testosterone levels and anabolic-androgenic steroids among males: a review. Sports Med 1990; 10:303-337
10. Schmitz G: Erfahrungen mit dem neuen synthetischen testes-hormon-preparat "Perandren." Deutsche Medizinische Wochenschrift 1937; 63:230-231
11. Werner AA: The male climacteric. JAMA 1939; 112:1441-1443
12. Davidoff E, Goodstone GL: Use of testosterone propionate in treatment of involutional psychosis in the male. Arch Neurol Psychiatry 1942; 48:811-817
13. Altschule MD, Tillotson KJ: The use of testosterone in the treatment of depression. N Engl J Med 1948; 239:1036-1038
14. Lamar CP: Clinical endrocrinology of the male: with special reference to the male climacteric. J Fla Med Assoc 1940; 26: 398-404
15. Kerman EF: Testosterone therapy of involutional psychosis. Arch Neurol Psychiatry 1943; 49:306-307
16. Pardoll DH, Belinson L: Androgen therapy in psychosis: effect of testosterone propionate in male involutional psychotics. J. Clin Endocrinol 1941; 1:138-141
17. Burns-Cox N, Gingell C: The andropause: fact or fiction? Postgrad Med J 1997; 73:553-556
18. Vermeulen A, Kaufman JM: Ageing of the hypothalamic-pituitary-testicular axis in men. Horm Res 1995; 43:25-28
19. Vermeulen A: Enviornment, human reproduction, menopause, and andropause. Enviorn Health Perspect 1993; 101 (suppl 2):91-100
20. McClure RD, Marshall L: Endocrinologic sexual dysfunction, in Sexual Dysfunction: A Neuro-Medical Approach. Edited by Singer C, Wiener WJ. Armonk, NY, Futura, 1994, pp 245-248
21. Rabkin JG, Rabkin R, Wagner GJ: Testosterone treatment of clinical hypogonadism in patients with HIV/AIDS. Int J STD AIDS 1997; 8:537-545
22. Boots LR, Potter S, Potter D, Azziz R: Measurement of total serum testosterone levels using commercially available kits: high degree of between-kit variability. Fertil Steril 1998; 69: 286-292
23. Morley JE, Kaiser FE, Perry HM III, Patrick P, Morley PM, Stauber PM, Vellas B, Baumgartner RN, Garry PJ: Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997; 46:410-413
24. Morley JE, Baranetsky NG, Wingert TD, Carlson HE, Hershman JM, Melmed S, Levin SR, Jamison KR, Weitzman R, Chan RJ, Varner AA: Endocrine effects of naloxone-induced opiate receptor blockade. J Clin Endocrinol Metab 1980; 50: 251-257
25. Billington CJ, Shafer RB, Morley JE: Effects of opioid block ade with nalmefene in older impotent men. Life Sci 1990; 47: 799-805
26. Bancroft J: Androgens, sexuality and the ageing male, in Endocrinology. Edited by Labrie F, Proulx L. Amsterdam, Elsevier, 1984, pp 913-916
27. Shain SA, Boesel RW: Age-associated diminishing rat prostrate and receptor concentration is concurrrent with decreased androgen dependence. Mech Ageing Dev 1997; 6: 219-282
28. Chatterjee B, Roy AK: Changes in hepatic androgen sensitivity and gene expression during aging. J Steroid Biochem Mol Biol 1990; 37:437-445
29. Harris MI: Epidemiology of diabetes mellitus among the elderly in the United States. Clin Geriatr Med 1990; 6:703-719
30. Davidson MB: The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism 1979; 28:688-705
31. Mariotti S, Franceschi C, Cossarinzza A, Pinchera A: The aging thyroid. Endocr Rev 1995; 16:686-715
32. Corpas E, Harman SM, Blackman MR: Human growth hormone and human aging. Endocr Rev 1993; 14:20-39
33. Ravaglia G, Forti P, Maioli F, Boschi F, Bernardi M, Pratelli L, Pizzoferrato A, Gasbarrini G: The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest old: results from an Italian study of healthy free-living over-ninety-year-olds. J Clin Endocrinol Metab 1996; 81:1173-1178
34. Hornsby PJ: Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline. Ann NY Acad Sci 1995; 774:29-46
35. Meacham RB, Murray MJ: Reproductive function in the aging male. Urol Clin North Am 1994; 21:549-556
36. Nieschlag E, Lammers U, Freischem CW, Langer K, Wickings EJ: Reproductive functions in young fathers and grandfathers. J Clin Endocrinol Metab 1982; 55:676-681
37. Schiavi RC, Rehman J: Sexuality and aging. Urol Clin North Am 1995; 22:711-726
38. Davidson JM, Camargo CA, Smith ER: Effects of androgen on sexual behavior in hypogonadal men. J Clin Endocrinol Metab 1979; 48:955-958
39. Bancroft J, Wu FCW: Changes in erectile responsiveness during androgen replacement therapy. Arch Sex Behav 1983; 12: 59-66
40. Carani C, Granata ARM, Bancroft J, Marrama P: The effects of testosterone replacement on nocturnal penile tumesence and rigidity and erectile response to visual erotic stimuli in hypogonadal men. Psychoneuroendocrinology 1995; 20:743-753
41. O'Carroll R, Bancroft J: Testosterone therapy for low sexual interest and erectile dysfunction in men: a controlled study. Br J Psychiatry 1984; 145:146-151
42. Kwan M, Greenleaf WJ, Mann J, Davidson JM: The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men. J Clin Endocrinol Metab 1983; 57:552-562
43. O'Carroll R, Shapiro C, Bancroft J: Androgens, behaviour and nocturnal erection in hypogonadal men: the effects of varying the replacement dose. Clin Endocrinol 1985; 23:527-538
44. Cunningham GR, Hirshkowitz M, Korenman SG, Karacan I: Testosterone replacement therapy and sleep-related erections in hypogonadal men. J Clin Endocrinol Metab 1990; 70: 792-797
45. Carani C, Scuteri A, Marrama P, Bancroft J: The effects of testosterone administration and visual erotic stimuli on nocturnal penile tumesence in normal men. Horm Behav 1990; 24:435-441
46. Schiavi RC, White D, Mandeli J: Pituitary-gonadal function during sleep in healthy aging men. Psychoneuroendocrinology 1992; 17:599-609
47. Schiavi RC, White D, Mandeli J, Schreiner-Engel P: Hormones and nocturnal penile tumesence in healthy aging men. Arch Sex Behav 1993; 22:207-215
48. Yaffe K, Sawaya G, Lieberburg I, Grady D: Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998; 279:688-695
49. Janowsky JS, Oviatt SK, Orwoll ES: Testosterone influences spatial cognition in older men. Behav Neurosci 1994; 108: 325-332
50. Christiansen K, Knussman R: Sex hormones and cognitive functioning in men. Neuropsychobiology 1987; 18:27-36
51. Gouchie C, Kimura D: The relationship between testosterone levels and cognitive ability patterns. Psychoneuroendocrinology 1991; 16:323-334
52. Moffat SD, Hampson E: A curvilinear relationship between testosterone and spatial cognition in humans: possible influences of hand preference. Psychoneuroendocrinology 1996; 21:323-337
53. Gordon HW, Lee PA: A relationship between gonadotropins and visuopatial function. Neuropsychologia 1986; 24:563-576
54. Vogel W, Broverman DM, Klaiber EL, Abraham G, Cone FL: Effects of testosterone infusions upon EEGs of normal male adults. Electroencephalogr Clin Neurophysiol 1971; 31:400-403
55. Kertzman C, Robinson DL, Sherins RJ, Schwankhaus JD, Mc Clurkin JW: Abnormalities in visual spatial attention in men with mirror movements associated with hypogonadotropic hypogonadism. Neurology 1990; 40:1057-1063
56. Cappa SF, Guariglia C, Papagno C. Pizzamiglio L, Vallar G, Zoccolotti P, Ambrosi B, Santiemma V: Patterns of lateralization and performance levels for verbal and spatial tasks in congenital androgen deficiency. Behav Brain Res 1988; 31: 177-183
57. Hampson E, Moffat SD: Is testosterone related to spatial cognition and hand preference in humans? Brain Cogn 1994; 26: 255-266
58. Sachar EJ, Halpern F, Rosenfeld RS, Gallagher TF, Hellman L: Plasma and urinary testosterone levels in depressed men. Arch Gen Psychiatry 1973; 28:15-18
59. Vogel W, Klaiber EL, Broverman DL: Roles of gonadal steroid hormones in psychiatric depression in men and women. Prog Neuropsychopharmacol 1978; 2:487-503
60. Yesavage JA, Davidson J, Widrow L, Berger PA: Plasma testosterone levels, depression, sexuality, and age. Biol Psychiatry 1985; 20:222-225
61. Levitt AJ, Joffe RT: Total and free testosterone in depressed men. Acta Psychiatr Scand 1988; 77:346-348
62. Rubin RT, Poland RE, Lesser IM: Neuroendocrine aspects of primary endogenous depression, VIII: pituitary-gonaldal axis activity in male patients and matched control subjects. Psychoneuroendocrinology 1989; 14:217-229
63. Davies RH, Harris B, Thomas DR, Cook N, Read G, Riad-Fahmy D: Salivary testosterone levels and major depressive illness in men. Br J Psychiatry 1992; 161:629-632
64. Danziger L, Schroeder HT, Unger AA: Androgen therapy for involutional melancholia. Arch Neurol Psychiatry 1944; 51: 457-461
65. Rubinow DR, Schmidt PJ: Androgens, brain, and behavior. Am J Psychiatry 1996; 153:974-984
66. Skakkebaek NE, Bancroft J, Davidson DW, Warner P: Androgen replacement with oral testosterone undeconoate in hypogonadal men: a double-blind controlled study. Clin Endocrinol 1981; 14:49-61
67. Salmimies P, Kockott G, Pirke KM, Vogt HJ, Schill WB: Effects of testosterone replacement on sexual behavior in hypogonadal men. Arch Sex Behav 1982; 11:345-353
68. Pirke KM, Kockott G: Endocrinology of sexual function. Clin Endocrinol Metab 1982; 11:625-637
69. Rabkin JG, Rabkin R, Wagner G: Testosterone replacement therapy in HIV illness. Gen Hosp Psychiatry 1995; 17:37-42
70. Anderson RA, Bancroft J, Wu FCW: The effects of exogenous testosterone on sexuality and mood of normal men. J Clin Endocrinol Metab 1992; 75:1503-1507
71. Schiavi RC, White D, Mandeli J, Levine AC: Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction. Arch Sex Behav 1997; 26:231-241
72. Tenover JS: Effects of testosterone supplementation in the aging male. J. Clin Endocrinol Metab 1992; 75:1092-1098
73. Sih R, Morley JE, Kaiser FE, Perry HM III, Patrick P, Ross C: Tesotsterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 1997; 82:1661-1667
74. Scane AC, Sutcliffe AM, Francis RM: Osteoporosis in men (review). Baillieres Clin Rheumatol 1993; 7:589-601
75. Jackson JA, Kleerekoper M, Parfitt AM, Rao DS, Villanueva AR, Frame B: Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab 1987; 65:53-58
76. Crilly RG, Francis RM, Nordin BE: Steroid hormones, ageing and bone. Clin Endocrinol Metab 1981; 10:115-139
77. Bhasin S, Bremner WJ: Emerging issues in androgen replacement theray. J Clin Endocrinol Metab 1997; 82:3-8
78. Schroder FH: Androgens and carcinoma of the prostate, in Testosterone Action, Deficiency, Substitution. Edited by Nieschlag E, Behre HM. Berlin, Springer Verlag, 1990, pp 245-260
79. Burris AS, Banks SM, Carter CS, Davidson JM, Sherins RJ: A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men. J Androl 1992; 13:297-304
80. Dorgan JF, Stanczyk FZ, Longcope C, Stephenson HE Jr, Chang L, Miller R, Franz C, Falk RT, Kahle L: Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal woman. Cancer Epidemiol Biomarkers Prev 1997; 6:177-181
81. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M: Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study. Science 1998; 279:563-566